DV Biomed Co., Ltd. (6539.TWO)

TWD 74.7

(2.05%)

EBITDA Summary of DV Biomed Co., Ltd.

  • DV Biomed Co., Ltd.'s latest annual EBITDA in 2023 was 407.64 Million TWD , down -29.41% from previous year.
  • DV Biomed Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 21.01 Million TWD , down 0.0% from previous quarter.
  • DV Biomed Co., Ltd. reported an annual EBITDA of 582.62 Million TWD in 2022, down -4.79% from previous year.
  • DV Biomed Co., Ltd. reported an annual EBITDA of 610.84 Million TWD in 2021, up 11.2% from previous year.
  • DV Biomed Co., Ltd. reported a quarterly EBITDA of 21.01 Million TWD for 2024 Q1, down -43.24% from previous quarter.
  • DV Biomed Co., Ltd. reported a quarterly EBITDA of 37.02 Million TWD for 2023 Q3, down -61.04% from previous quarter.

Annual EBITDA Chart of DV Biomed Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of DV Biomed Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 407.64 Million TWD -29.41%
2022 582.62 Million TWD -4.79%
2021 610.84 Million TWD 11.2%
2020 545.47 Million TWD 110.83%
2019 247.86 Million TWD 0.0%

Peer EBITDA Comparison of DV Biomed Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -99.051%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD -76.396%
Easywell Biomedicals, Inc. -85.5 Million TWD 576.766%
TTY Biopharm Company Limited 1.52 Billion TWD 73.259%
Synmosa Biopharma Corporation 1 Billion TWD 59.589%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 30.071%
Center Laboratories, Inc. -175.17 Million TWD 332.711%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -1212.935%
Orient Pharma Co., Ltd. 172.39 Million TWD -136.457%
InnoPharmax Inc. -62.12 Million TWD 756.214%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -221.792%
Excelsior Biopharma Inc. -29.36 Million TWD 1487.994%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 144.69%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 49.222%
UniPharma Co., Ltd. -16.25 Million TWD 2607.937%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -210.441%
Alar Pharmaceuticals Inc. 394.52 Million TWD -3.326%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -78.535%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 1144.32%
Bioray Biotech Co., Ltd 12.13 Million TWD -3259.209%
TSH Biopharm Corporation Limited 99.35 Million TWD -310.307%